Anna MacDonald
Science Writer
After obtaining a first-class honours degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.
Latest Content
Infographic
Organs-on-Chips: Furthering Our Understanding of Disease
Download this infographic to explore what OOCs are and how they are helping to further our understanding of disease.
Infographic
Data Integrity Risks
Download this infographic to explore what data integrity is, why it is so important and how common data integrity risks can be avoided.
Industry Insight
Probing the Biomarker Landscape of Human Disease
To find out more about the importance of improving biomarker discovery and how next-generation mass spectrometry-based systems can help to fill the current gap in biomarker technologies, Technology Networks spoke with Dr. Mo Jain.
Infographic
Cell Signaling in Disease
Download this infographic to explore why cell signaling is important, how Wnt signaling is involved in cancer and the role of the JAK/STAT pathway in neurodegenerative disease.
Industry Insight
High-Precision T-Cell Testing: Driving Diagnostics Forward
To learn more about T-cell testing, the types of diseases it can help to diagnose and its value in clinical trials, we spoke to Phill Keefe, chief executive officer of PerkinElmer’s Oxford Immunotec division.
Industry Insight
Streamlining Lead Identification
To learn more about the Pioneer Antibody Discovery Platform and its potential impact on drug discovery and development, we spoke to Dr. John Cardone.
Industry Insight
What’s on the Horizon for Clinical Trials in 2023?
From increasing trial diversity to using plants to manufacture drugs, the experts weigh in.
Industry Insight
Leading by Example, Challenging the Sustainability Mindset
We spoke to Darlene Solomon to learn more about improving sustainability in science and Agilent’s commitment to My Green Lab and other sustainability initiatives.
Infographic
Disease Modeling
In this infographic, we explore what is meant by disease modeling and highlight how advanced cell models are helping researchers to overcome some of the limitations associated with classical cell lines and animal models.
Industry Insight
Building a More Resilient Biopharma Industry
Technology Networks spoke to Conor McKechnie, to learn more about the Biopharma Resilience Index and the changes required to get new therapeutics to market quicker.
Advertisement
